| SYS | | 0076464 |
|---|
| LBL | | 00000naa^^22^^^^^^^^450 |
|---|
| 005 | | 20120615135728.9 |
|---|
| 100 | | $a 20120522a2012 m y0sloy0103 ba |
|---|
| 101 | 0- | $a slo |
|---|
| 102 | | $a SK |
|---|
| 200 | 1- | $a Účinky nového inhibítora aldosterónsyntázy v liečbe primárnej hypertenzie $d Effects of a novel aldosterone synthase inhibitor for treatment of primary hypertension : results of a randomized, double-blind, placebo- and active-controlled phase 2 trial $f Miroslav Šašinka $z eng |
|---|
| 305 | | $a Calhoun, D.A., White, W. B., Krum, H., Guo, W., Bermann, G., Trapani, A., Lefkowitz, M. P., Ménard, J.: Circulation, 125, 2012, s. 199-202 |
|---|
| 463 | -1 | $1 001 sllk_un_cat*0076284 $1 011 $a 0457-4214 $1 200 1 $a Lekársky obzor $e odborný časopis Slovenskej zdravotníckej univerzity v Bratislave $v Roč. 61, č. 2-3 (2012), s. 51 $1 210 $a Bratislava $c HERBA $d 2012 $1 215 $a s. 43-108 |
|---|
| 510 | 1- | $a Effects of a novel aldosterone synthase inhibitor for treatment of primary hypertension : results of a randomized, double-blind, placebo- and active-controlled phase 2 trial $z eng |
|---|
| 606 | 1- | $3 sllk_un_auth*d006973 $a hypertenzia $x farmakoterapia $2 mesh |
|---|
| 606 | 1- | $3 sllk_un_auth*d016032 $a skúšanie randomizované kontrolované ako téma $2 mesh |
|---|
| 606 | 1- | $3 sllk_un_auth*d017322 $a skúšanie klinické, fáza II, ako téma $2 mesh |
|---|
| 606 | 2- | $3 sllk_un_auth*d015507 $a lieky skúšané $x aplikácia a dávkovanie $x farmakológia $2 mesh |
|---|
| 606 | 2- | $3 sllk_un_auth*d019405 $a cytochróm P-450 CYP11B2 $x antagonisty a inhibítory $2 mesh |
|---|
| 608 | | $3 sllk_un_auth*d020504 $a abstrakty $2 mesh |
|---|
| 700 | -1 | $3 sllk_un_auth*p0001277 $a Šašinka $b Miroslav $f 1935-2019 $p Klinika detí a dorastu SZU, Bratislava $4 010 |
|---|
| 801 | -0 | $a SK $b BA006 $c 20120522 $g AACR2 |
|---|
